These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30171073)

  • 1. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R.
    Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR
    J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential receptor subunit affinities of type I interferons govern differential signal activation.
    Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
    J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.
    Liptáková H; Kontseková E; Alcamí A; Smith GL; Kontsek P
    Virology; 1997 May; 232(1):86-90. PubMed ID: 9185591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities.
    Kalie E; Jaitin DA; Podoplelova Y; Piehler J; Schreiber G
    J Biol Chem; 2008 Nov; 283(47):32925-36. PubMed ID: 18801736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
    Lamken P; Lata S; Gavutis M; Piehler J
    J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta.
    Vancová I; La Bonnardiere C; Kontsek P
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1647-9. PubMed ID: 9680126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
    Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
    Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Structure in the Biology of Interferon Signaling.
    Walter MR
    Front Immunol; 2020; 11():606489. PubMed ID: 33281831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells.
    Ickler J; Francois S; Widera M; Santiago ML; Dittmer U; Sutter K
    PLoS One; 2020; 15(1):e0218905. PubMed ID: 31935222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S27 of IFNα1 Contributes to Its Low Affinity for IFNAR2 and Weak Antiviral Activity.
    Sharma N; O'Neal AJ; Gonzalez C; Wittling M; Gjinaj E; Parsons LM; Panda D; Khalenkov A; Scott D; Misra S; Rabin RL
    J Interferon Cytokine Res; 2019 May; 39(5):283-292. PubMed ID: 30920934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted activities of type I interferon are revealed by a receptor antagonist.
    Levin D; Schneider WM; Hoffmann HH; Yarden G; Busetto AG; Manor O; Sharma N; Rice CM; Schreiber G
    Sci Signal; 2014 May; 7(327):ra50. PubMed ID: 24866020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.
    Stifter SA; Matthews AY; Mangan NE; Fung KY; Drew A; Tate MD; Soares da Costa TP; Hampsey D; Mayall J; Hansbro PM; Garcia Minambres A; Eid SG; Mak J; Scoble J; Lovrecz G; deWeerd NA; Hertzog PJ
    J Biol Chem; 2018 Mar; 293(9):3168-3179. PubMed ID: 29187603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
    Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
    Front Immunol; 2018; 9():2589. PubMed ID: 30473701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
    Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
    Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.
    Alcamí A; Symons JA; Smith GL
    J Virol; 2000 Dec; 74(23):11230-9. PubMed ID: 11070021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon Kappa Is Important for Keratinocyte Host Defense against Herpes Simplex Virus-1.
    Li Y; Song Y; Zhu L; Wang X; Richers B; Leung DYM; Bin L
    J Immunol Res; 2020; 2020():5084682. PubMed ID: 32352019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.